Biocon Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

600.30

600.30

600.00

600.00

300.00

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

10,314.80

7,491.70

7,306.20

6,936.40

6,814.50

Loan funds

Secured loans

1,297.70

75.90

-

0.70

1.40

Unsecured loans

-

-

-

-

-

Total

12,212.80

8,167.90

7,906.20

7,537.10

7,115.90

Uses of funds

Fixed assets

Gross block

2,338.10

2,144.80

1,980.90

1,889.30

2,508.40

Less : revaluation reserve

0.90

0.90

0.90

0.90

0.90

Less : accumulated depreciation

1,376.70

1,274.60

1,182.80

1,096.10

1,407.30

Net block

960.50

869.30

797.20

792.30

1,100.20

Capital work-in-progress

343.50

284.90

179.20

151.90

254.50

Investments

9,270.70

5,280.00

5,412.70

4,952.80

4,016.20

Net current assets

Current assets, loans & advances

2,454.30

2,433.90

2,183.70

2,412.90

2,868.60

Less : current liabilities & provisions

816.20

700.20

666.60

772.80

1,123.60

Total net current assets

1,638.10

1,733.70

1,517.10

1,640.10

1,745.00

Miscellaneous expenses not written

-

-

-

-

-

Total

12,212.80

8,167.90

7,906.20

7,537.10

7,115.90

Notes:

Book value of unquoted investments

7,199.20

2,614.70

2,616.80

2,229.80

1,286.80

Market value of quoted investments

13,096.50

16,871.80

15,346.80

6,798.30

8,374.10

Contingent liabilities

754.80

638.30

1,749.60

2,203.70

1,932.80

Number of equity sharesoutstanding (Lacs)

12006.00

12006.00

12000.00

12000.00

6000.00